High-Throughput Screening for Human Lysosomal β-N-Acetyl Hexosaminidase Inhibitors Acting as Pharmacological Chaperones
- 28 February 2007
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 14 (2), 153-164
- https://doi.org/10.1016/j.chembiol.2006.12.006
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Crystallographic Structure of Human β-Hexosaminidase A: Interpretation of Tay-Sachs Mutations and Loss of GM2 Ganglioside HydrolysisJournal of Molecular Biology, 2006
- Novel Five‐Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and OsteoarthritisChemBioChem, 2006
- Intracellular Protein Degradation: From a Vague Idea, through the Lysosome and the Ubiquitin–Proteasome System, and onto Human Diseases and Drug Targeting (Nobel Lecture)Angewandte Chemie International Edition, 2005
- Pharmacological chaperones: potential treatment for conformational diseasesTrends in Endocrinology & Metabolism, 2004
- The X-ray Crystal Structure of Human β-Hexosaminidase B Provides New Insights into Sandhoff DiseaseJournal of Molecular Biology, 2003
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- N-Acetylglucosaminidase (chitobiase) from Serratia marcescens: gene sequence, and protein production and purification in Escherichia coliGene, 1996
- Synthesis and Inhibitory Properties of 2-Acetamido-2-Deoxynojirimycin (2-Acetamido-5-amino-2,5-dideoxy-D-glucopyranose,1) and 2-Acetamido-1,2-dideoxynojirimycin (2-Acetamido-1,5-imino-1,2,5-trideoxy-D-Glucitol, 2)Journal of Carbohydrate Chemistry, 1989
- A Decade of Developments in Diuretic Drug TherapyThe Journal of Clinical Pharmacology, 1986
- GM1-gangliosidosis (Type II): Studies on a fibroblast cell strainBiochemical Medicine, 1970